Creo Medical Limited (LON:CREO – Get Rating) insider Charles Spicer purchased 15,435 shares of Creo Medical stock in a transaction that occurred on Thursday, May 26th. The stock was purchased at an average cost of GBX 97 ($1.22) per share, for a total transaction of £14,971.95 ($18,839.75).
CREO stock opened at GBX 97.60 ($1.23) on Friday. The business’s 50-day moving average is GBX 105.50 and its two-hundred day moving average is GBX 127.69. The company has a debt-to-equity ratio of 20.53, a quick ratio of 2.17 and a current ratio of 2.52. Creo Medical Limited has a fifty-two week low of GBX 94 ($1.18) and a fifty-two week high of GBX 220 ($2.77). The company has a market cap of £176.66 million and a price-to-earnings ratio of -7.17.
Creo Medical Company Profile (Get Rating)
- Is RBC Bearings Rolling Into A Reversal?
- Should Dollar General or Dollar Tree Give Investors a Case of FOMO?
- Genesco Pops On Earnings But Don’t Expect A Rally
- The Insiders Are Selling Movado Group, But You Shouldn’t
- Beware The Rebound In Retail Stocks
Receive News & Ratings for Creo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical and related companies with MarketBeat.com's FREE daily email newsletter.